Pancreatic Cancer Research

ResearcherSanford Burnham Prebys Medical Discovery InstituteActive in the last 2 years

Linda M. Bradley

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8697-8565; OpenAlex author ID A5020853472; NIH RePORTER profile ID 1940901. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 1 grant

Papers 3

  1. Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2025.06.021↗
  2. Disabling PSGL-1 abrogates immune suppression and resistance to PD-1 blockade in pancreatic cancer Last author DOI 10.1101/2025.05.22.655365↗
  3. Macropinocytosis controls metabolic stress-driven CAF subtype identity in pancreatic cancer Co-author DOI 10.1101/2024.11.29.625709↗

Grants 1

  1. Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer R21CA293150↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yijuan Zhang · 3 shared papers, 2024–2025 · strength 0.60
  2. Jennifer L. Hope · 3 shared papers, 2024–2025 · strength 0.60
  3. Cosimo Commisso · 3 shared papers, 2024–2025 · strength 0.60
  4. Cheska Marie Galapate · 2 shared papers, 2024–2025 · strength 0.40
  5. Anindya Bagchi · 2 shared papers, 2024–2025 · strength 0.40
  6. Andrew M. Lowy · 2 shared papers, 2024–2025 · strength 0.40
  7. Yoav Altman · 1 shared paper, 2025 · strength 0.20
  8. Ling Li · 1 shared paper, 2025 · strength 0.20
  9. Katelyn T. Byrne · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.